Vialize

The Next Generation Placental Membrane Allograft for Hospital Use

Vialize, a lyophilized dehydrated complete human placental membrane (dCHPM) allograft, is designed for use as a wound covering or barrier membrane. Unlike many other placental allografts that typically contain one or two layers of the placental membrane, Vialize retains all three layers of the membrane using the patented Clearify® technology.¹ Vialize allografts are never delaminated allowing for optimal preservation of the 3D architecture of the native tissue.

4x thicker, 6x more growth factors, 4x more protein than the competitor graft^1,2

Easy to handle and apply

Retains key structural components and proteins¹

Connect with a StimLabs Representative

Case Reports Common Clinical Applications Video Gallery Sizes and SKUs

Case Reports

Common Clinical Applications

Procedure Types

Amputations
Hysterectomies
Lumbar & Cervical Fusions
Myomectomies
Surgical Wounds
Tendon & Ligament Repairs
Traumatic Wounds
Ulcers

Specialties

General Surgery
OBGYN
Orthopedic Surgery
Plastic Surgery
Podiatry
Spine & Neurosurgery
Vascular Surgery

Intended Use

Video Gallery

Robotic Laparoscopic Myomectomy with Placement of Lyophilized dCHPM Allograft

Sizes and SKUs


		Size	2 x 3 cm	4 x 4 cm	4x6 cm	6x8 cm	2 x 12 cm
SKU	VL-2030	VL-4040	VL-4060	VL-6080	VL-0212

Sheet format: Shelf-stable for up to five (5) years

Vialize is intended to be used as a wound covering or barrier membrane. Vialize complements standard of care as a barrier membrane following primary repair or closure. 1. Data on file. 2. Data is compared to the leading dual-layer allograft and reported as an average. Patents: www.stimlabs.com/patents